Lori Lawley

Financieel Directeur/CFO bij LUMOS PHARMA, INC.

42 jaar

Health Technology

Commercial Services

Consumer Services

Profiel

Lori Lawley is currently Chief Financial Officer & Secretary at Lumos Pharma, Inc. since 2020.
Former positions include Vice President-Finance & Controller at NewLink Genetics Corp.
from 2018 to 2020 and Senior Manager at Ernst & Young LLP from 2014 to 2015.
Education includes undergraduate and graduate degrees from McCombs School of Business.

Actieve functies van Lori Lawley

Bedrijven	Functie	Begin
LUMOS PHARMA, INC.	Financieel Directeur/CFO	04-07-2021

Alle actieve functies van Lori Lawley

Eerdere bekende functies van Lori Lawley

Bedrijven	Functie	Einde
LUMOS PHARMA, INC.	Comptroller/Controller/Auditor	01-03-2020
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Corporate Officer/Principal	01-04-2015

Ervaring van Lori Lawley in detail bekijken

Opleiding van Lori Lawley

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Lori Lawley in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	4
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Commercial Services
NewLink Genetics Corp. NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer	Health Technology
McCombs School of Business McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lumos Pharma, Inc. Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases	Health Technology